CytRx Short Interest Ratio and Short Volume

Short interest is the volume of CytRx shares that have been sold short but have not yet been closed out or covered. As of February 12th, investors have sold 42,400 shares of CYTR short.

CytRx saw a decrease in short interest in the month of February. As of February 12th, there was short interest totaling 42,400 shares, a decrease of 9.6% from the previous total of 46,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of CytRx's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to CytRx: Gritstone Oncology, Inc. (8.43%), Fusion Pharmaceuticals Inc. (1.62%), Harpoon Therapeutics, Inc. (2.94%), AVROBIO, Inc. (0.00%), Freeline Therapeutics Holdings plc (0.09%), Opthea Limited (0.00%), Innate Pharma S.A. (0.00%), Innate Pharma S.A. (0.00%), Codiak BioSciences, Inc. (3.24%), and Cardiff Oncology, Inc. (18.60%).

As of the most recent reporting period, the following stocks had the largest short interest positions: ViacomCBS Inc. ($6.50 billion), Aon Plc ($5.58 billion), Charter Communications, Inc. ($5.30 billion), Analog Devices, Inc. ($4.97 billion), Snap Inc. ($3.80 billion), Futu Holdings Limited ($2.84 billion), Airbnb, Inc. ($2.40 billion), Discovery, Inc. ($2.35 billion), Snowflake Inc. ($2.07 billion), and The Kroger Co. ($2.00 billion). View all of the most shorted stocks.

Short selling CYTR is an investing strategy that aims to generate trading profit from CytRx as its price is falling. CytRx's stock is trading up $0.12 today. To short CytRx stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that CytRx will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CytRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CYTR, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CYTR, twice per month. The most recent reporting period available is February, 12 2021.